50342-31-9

Upstream product

• 186581-53-3 diazomethane 
• 101257-48-1 5-methoxy-4-methyl-2-nitrophenol 
• 855754-07-3 Methyl-(6-nitro-3-hydroxy-4-methyl-phenyl)-aether 
• 7149-77-1 1,5-dichloro-2-methyl-4-nitrobenzene 
• 124-41-4 sodium methylate 
• 112251-88-4 4-methyl-2,5-dinitroanisole 
• 77-78-1 dimethyl sulfate 
• 67-56-1 methanol 
• 97655-37-3 1-chloro-5-methoxy-4-methyl-2-nitrobenzene 
• 13852-51-2 5-chloro-2-methyl-4-nitroaniline 
• 50868-72-9 5-methoxy-o-toluidine 
• 20734-74-1 5-methoxy-2-methyl-phenol 
• 19217-50-6 4-methyl-3-(methyloxy)phenol 
• 38064-95-8 2,4-dimethoxy-5-methylacetophenone 

Downstream Products

• 82477-59-6 2,4-dimethoxy-5-methylaniline 

Relevant academic research and scientific papers

ANTIBIOTIC COMPOUNDS

The present invention relates to antibiotic compounds of formula (I), to compositions containing these compounds and to methods of treating bacterial diseases and infections using the compounds. The compounds find application in the treatment of infection with, and diseases caused by, Gram-positive and/or Gram-negative bacteria, and in particular in the treatment of infection with, and diseases caused by, Neisseria gonorrhoeae.

Positive allosteric modulators of the nicotinic acetylcholine receptor

The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in which α7 nAChR is known to be involved.